Clinical Trial Update: IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes that MG-K10 is being studied in adolescents with moderately severe atopic dermatitis in a Phase 1/Phase 2 program and is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• MG-K10

Snippet

Sponsor: Shanghai Mabgeek Biotech.Co.Ltd | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: RECRUITING